A Multi-site, Open-Label, Pilot Study to Evaluate the Benefit of Octagam 5% in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Immune globulin (Primary)
- Indications Streptococcal infections
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms PANS
- 05 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 02 Jan 2018 Status changed from not yet recruiting to recruiting.
- 24 Nov 2017 New trial record